Suppr超能文献

COVID-19 与医院管理成本:意大利的经验。

COVID-19 and hospital management costs: the Italian experience.

机构信息

Healthcare Datascience Lab (HD LAB), Centre for Health Economics, Social and Health Care Management, Carlo Cattaneo - LIUC University, 21053, Castellanza, Italy.

出版信息

BMC Health Serv Res. 2022 Aug 4;22(1):991. doi: 10.1186/s12913-022-08365-9.

Abstract

BACKGROUND

This article investigates the hospital costs related to the management of COVID-19 positive patients, requiring a hospitalization (from the positivity confirmation to discharge, including rehabilitation activities).

METHODS

A time-driven activity-based costing analysis, grounding on administrative and accounting flows provided by the management control, was implemented to define costs related to the hospital management of COVID-19 positive patients, according to real-word data, derived from six public Italian Hospitals, in 2020.

RESULTS

Results reported that the higher the complexity of care, the higher the hospitalization cost per day (low-complexity = €475.86; medium-complexity = €700.20; high-complexity = €1,401.65). Focusing on the entire clinical pathway, the overall resources absorption, with the inclusion of rehabilitation costs, ranged from 6,198.02€ to 32,141.20€, dependent from the patient's clinical condition.

CONCLUSIONS

Data could represent the baseline cost for COVID-19 hospital management, thus being useful for the further development of proper reimbursement tariffs devoted to hospitalized infected patients.

摘要

背景

本文研究了与管理 COVID-19 阳性患者相关的医院成本,这些患者需要住院治疗(从阳性确诊到出院,包括康复活动)。

方法

根据管理控制提供的行政和会计流程,采用时间驱动的作业成本分析方法,根据 2020 年六家意大利公立医院的实际数据,确定与 COVID-19 阳性患者的医院管理相关的成本。

结果

结果表明,护理复杂性越高,每天的住院费用越高(低复杂性=475.86 欧元;中复杂性=700.20 欧元;高复杂性=1401.65 欧元)。从整个临床路径来看,包括康复费用在内的整体资源消耗从 6198.02 欧元到 32141.20 欧元不等,取决于患者的临床状况。

结论

数据可以代表 COVID-19 医院管理的基准成本,因此对于制定专门用于感染住院患者的适当报销费率非常有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/dae2a4602c43/12913_2022_8365_Fig1_HTML.jpg

相似文献

1
COVID-19 and hospital management costs: the Italian experience.
BMC Health Serv Res. 2022 Aug 4;22(1):991. doi: 10.1186/s12913-022-08365-9.
3
Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy.
Clin Drug Investig. 2021 Feb;41(2):183-191. doi: 10.1007/s40261-020-00991-7. Epub 2021 Feb 9.
4
Cost Analysis of Hospitalization for COVID-19 in a Brazilian Public Teaching Hospital.
Value Health Reg Issues. 2023 Mar;34:48-54. doi: 10.1016/j.vhri.2022.10.006. Epub 2022 Dec 2.
6
Costs of children with medical complexity in Australian public hospitals.
J Paediatr Child Health. 2016 May;52(5):566-71. doi: 10.1111/jpc.13152.
7
Cost of Illness in Patients With COVID-19 Admitted in Three Brazilian Public Hospitals.
Value Health Reg Issues. 2023 Jul;36:34-43. doi: 10.1016/j.vhri.2023.02.004. Epub 2023 Apr 3.
8
COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors.
Braz J Infect Dis. 2021 Jul-Aug;25(4):101609. doi: 10.1016/j.bjid.2021.101609. Epub 2021 Aug 19.

引用本文的文献

1
[Not Available].
Glob Reg Health Technol Assess. 2025 Jul 17;12:168-176. doi: 10.33393/grhta.2025.3403. eCollection 2025 Jan-Dec.
2
Facility Management Costs for Hospital Infrastructures: Insights from the Italian Healthcare System.
Healthcare (Basel). 2025 Apr 17;13(8):924. doi: 10.3390/healthcare13080924.
3
Measuring productivity in the healthcare sector: a bibliometric and content analysis.
Health Econ Rev. 2025 Mar 18;15(1):24. doi: 10.1186/s13561-025-00612-z.
7
What Makes a Hospital Excellent? A Qualitative Study on the Organization and Management of Five Leading Public Hospitals in China.
Risk Manag Healthc Policy. 2023 Sep 18;16:1915-1927. doi: 10.2147/RMHP.S424711. eCollection 2023.
8
Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain.
Front Public Health. 2023 Aug 1;11:1229561. doi: 10.3389/fpubh.2023.1229561. eCollection 2023.
10
Treatment cost assessment for COVID-19 inpatients in Shenzhen, China 2020-2021: facts and suggestions.
Front Public Health. 2023 May 4;11:1066694. doi: 10.3389/fpubh.2023.1066694. eCollection 2023.

本文引用的文献

1
Indirect impact of Covid-19 on hospital care pathways in Italy.
Sci Rep. 2021 Nov 2;11(1):21526. doi: 10.1038/s41598-021-00982-4.
2
Epidemiological and economic impact of COVID-19 in the US.
Sci Rep. 2021 Oct 14;11(1):20451. doi: 10.1038/s41598-021-99712-z.
4
Inpatient Hospital Costs for COVID-19 Patients in the United States.
Adv Ther. 2021 Nov;38(11):5557-5595. doi: 10.1007/s12325-021-01887-4. Epub 2021 Oct 5.
5
Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis.
Sci Rep. 2021 Sep 7;11(1):17787. doi: 10.1038/s41598-021-97259-7.
6
Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review.
Ann Med. 2021 Dec;53(1):318-334. doi: 10.1080/07853890.2021.1875500.
7
A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States.
Adv Ther. 2021 Apr;38(4):1811-1831. doi: 10.1007/s12325-021-01654-5. Epub 2021 Feb 27.
8
Prediction of the COVID-19 outbreak in China based on a new stochastic dynamic model.
Sci Rep. 2020 Dec 9;10(1):21522. doi: 10.1038/s41598-020-76630-0.
9
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.
Lancet Glob Health. 2021 Feb;9(2):e120-e129. doi: 10.1016/S2214-109X(20)30452-6. Epub 2020 Nov 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验